NASDAQ: CLBTCellebrite DI Ltd Stock Ownership - Who owns Cellebrite DI?
Insider buying vs selling
Have Cellebrite DI Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Thomas E. Hogan | Chief Executive Officer | 2026-07-02 | 103,188 | $15.76 | $1.63MSell |
| David Nicholas Gee | Chief Marketing Officer | 2026-05-21 | 2,243 | $13.10 | $29.38kSell |
| David Nicholas Gee | Chief Marketing Officer | 2026-05-21 | 3,430 | $13.15 | $45.09kSell |
| Marcus Jewell | Global Chief Revenue Officer | 2026-05-18 | 12,658 | $12.77 | $161.66kSell |
| David Nicholas Gee | Chief Marketing Officer | 2026-05-12 | 228 | $13.01 | $2.97kSell |
| Marcus Jewell | Global Chief Revenue Officer | 2026-05-12 | 383 | $13.01 | $4.98kSell |
CLBT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CLBT insiders and whales buy or sell their stock.
CLBT Shareholders
What type of owners hold Cellebrite DI Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Adam Clammer | 5.96% | 14,682,403 | $243.29M | Insider |
| True Wind Capital Management LP | 5.62% | 13,861,007 | $229.68M | Institution |
| Voss Capital LP | 3.93% | 9,675,000 | $160.31M | Institution |
| Fmr LLC | 3.44% | 8,489,643 | $140.67M | Institution |
| Pertento Partners LLP | 2.70% | 6,662,654 | $110.40M | Institution |
| Phoenix Financial Ltd | 1.70% | 4,181,269 | $69.28M | Institution |
| Nine Ten Capital Management LLC | 1.40% | 3,443,875 | $57.07M | Institution |
| Blackrock Inc | 1.35% | 3,339,645 | $55.34M | Institution |
| T Rowe Price Investment Management Inc | 1.35% | 3,315,392 | $54.94M | Institution |
| Clal Insurance Enterprises Holdings Ltd | 1.29% | 3,173,014 | $52.58M | Institution |
CLBT vs Software Infrastructure Stocks
Cellebrite DI Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.